Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Files

675692.pdf (2.7 MB)

Document type

Article

Version

Published version

Publication date

2017-07-11

Publication license

cc-by (c) Daldin et al., 2017
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/126545

Polyglutamine expansion affects huntingtin conformation in multiple Huntington's disease models

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

https://doi.org/10.1038/s41598-017-05336-7

Abstract

Conformational changes in disease-associated or mutant proteins represent a key pathological aspect of Huntington's disease (HD) and other protein misfolding diseases. Using immunoassays and biophysical approaches, we and others have recently reported that polyglutamine expansion in purified or recombinantly expressed huntingtin (HTT) proteins affects their conformational properties in a manner dependent on both polyglutamine repeat length and temperature but independent of HTT protein fragment length. These findings are consistent with the HD mutation affecting structural aspects of the amino-terminal region of the protein, and support the concept that modulating mutant HTT conformation might provide novel therapeutic and diagnostic opportunities. We now report that the same conformational TR-FRET based immunoassay detects polyglutamine-and temperaturedependent changes on the endogenously expressed HTT protein in peripheral tissues and post-mortem HD brain tissue, as well as in tissues from HD animal models. We also find that these temperatureand polyglutamine-dependent conformational changes are sensitive to bona-fide phosphorylation on S13 and S16 within the N17 domain of HTT. These findings provide key clinical and preclinical relevance to the conformational immunoassay, and provide supportive evidence for its application in the development of therapeutics aimed at correcting the conformation of polyglutamine-expanded proteins as well as the pharmacodynamics readouts to monitor their efficacy in preclinical models and in HD patients.

Subject

Corea de Huntington, Malalties neurodegeneratives, Mutació (Biologia)

Subject (English)

Huntington's chorea, Neurodegenerative Diseases, Mutation (Biology)

Citation

Collections

Articles publicats en revistes (Biomedicina)

Citation

DALDIN, Manuel, et al. Polyglutamine expansion affects huntingtin conformation in multiple Huntington's disease models. Scientific Reports. 2017. Vol. 7. ISSN 2045-2322. [consulted: 16 of August of 2026]. Available at: https://hdl.handle.net/2445/126545

Export metadata

JSON - METS

Share record